Patents by Inventor Jean-Christophe Sabourin

Jean-Christophe Sabourin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of cancer using TLR3 agonists
    Patent number: 8409813
    Abstract: The present invention relates generally to the fields of genetics and medicine. More specifically, the present invention relates to improved methods of treating cancers using a TLR3 agonist, by assessing the expression of a TLR3 receptor by cancer cells.
    Type: Grant
    Filed: May 26, 2010
    Date of Patent: April 2, 2013
    Assignee: Institut Gustave Roussy
    Inventors: Fabrice Andre, Laurence Zitvogel, Jean-Christophe Sabourin
  • Treatment of Cancer Using TLR3 Agonists
    Publication number: 20100266680
    Abstract: The present invention relates generally to the fields of genetics and medicine. More specifically, the present invention relates to improved methods of treating cancers using a TLR3 agonist, by assessing the expression of a TLR3 receptor by cancer cells.
    Type: Application
    Filed: May 26, 2010
    Publication date: October 21, 2010
    Applicant: INSTITUT GUSTAVE ROUSSY
    Inventors: Fabrice Andre, Laurence Zitvogel, Jean-Christophe Sabourin
  • Treatment of Cancer Using Tlr3 Agonists
    Publication number: 20080317811
    Abstract: The present invention relates generally to the fields of genetics and medicine. More specifically, the present invention relates to improved methods of treating cancers using a TLR3 agonist, by assessing the expression of TLR3 receptor by cancer cells.
    Type: Application
    Filed: November 18, 2005
    Publication date: December 25, 2008
    Applicant: Institut Gustave Roussy
    Inventors: Fabrice Andre, Laurence Zitvogel, Jean-Christophe Sabourin
  • TREATMENT OF CANCER USING TLR3 AGONISTS
    Publication number: 20080253998
    Abstract: The present invention relates generally to the fields of genetics and medicine. More specifically, the present invention relates to improved methods of treating cancers using a TLR3 agonist, by assessing the expression of a TLR3 receptor by cancer cells.
    Type: Application
    Filed: May 19, 2008
    Publication date: October 16, 2008
    Applicant: INSTITUT GUSTAVE ROUSSY
    Inventors: FABRICE ANDRE, Laurence Zitvogel, Jean-Christophe Sabourin
  • Treatment of cancer using TLR3 agonists
    Patent number: 7378249
    Abstract: The present invention relates generally to the fields of genetics and medicine. More specifically, the present invention relates to improved methods of treating cancers using a TLR3 agonist, by assessing the expression of a TLR3 receptor by cancer cells.
    Type: Grant
    Filed: June 3, 2005
    Date of Patent: May 27, 2008
    Assignee: Institut Gustave Roussy
    Inventors: Fabrice Andre, Laurence Zitvogel, Jean-Christophe Sabourin
  • Treatment of cancer using TLR3 agonists
    Publication number: 20060110746
    Abstract: The present invention relates generally to the fields of genetics and medicine. More specifically, the present invention relates to improved methods of treating cancers using a TLR3 agonist, by assessing the expression of a TLR3 receptor by cancer cells.
    Type: Application
    Filed: June 3, 2005
    Publication date: May 25, 2006
    Applicant: Institut Gustave Roussy
    Inventors: Fabrice Andre, Laurence Zitvogel, Jean-Christophe Sabourin